Thermo Fisher reports Q2 adjusted EPS $5.37, consensus $5.12

Reports Q2 revenue $10.54B, consensus $10.51B. “Our excellent execution enabled us to deliver another quarter of strong financial performance and share gain,” said Marc Casper, chairman, president, and chief executive officer of Thermo Fisher Scientific. “We continue to see the benefit of our proven growth strategy and the impact of our PPI Business System in our performance. Shortly after the quarter ended, we were also pleased to welcome our Olink colleagues to Thermo Fisher and are excited about the power of this new combination to better serve our customers and advance science.” Casper added, “We have made very good progress through the halfway point of the year and are in a great position to deliver differentiated performance in 2024. We’ve further extended our industry leadership and positioned our company for an even brighter future.”